Evaxion A/S: Financial statements 2025
CVR: 31762863
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Evaxion A/S (CVR 31762863) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. That is an increase of 115.5% compared with the year before. The profit margin was -107%. Equity in the 2025 report amounted to DKK 108,250,000. The solvency ratio was 60%. The company had 45 employees in the financial year.
- Revenue
- DKK 48,112,000
- Gross Profit
- DKK 48,112,000
- Profit/Loss
- DKK -51,489,000
- Equity
- DKK 108,250,000
- Total Assets
- DKK 180,463,000
- Employees
- 45
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 48.1 mio. | 48.1 mio. | -51.5 mio. | 108.3 mio. | 45 |
| 2024 | 22.3 mio. | 22.3 mio. | -73.3 mio. | -11.8 mio. | 46 |
| 2023 | 507 t. | 507 t. | -152.4 mio. | -31.9 mio. | 55 |
| 2022 | - | - | -164.3 mio. | 57.9 mio. | 59 |
| 2021 | - | - | -154.9 mio. | 212.8 mio. | 53 |
Official annual report
How creditworthy is Evaxion A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 24, 2025, Helen Katrina Tayton-Martin has left the board of directors of Evaxion A/S.
As of November 24, 2025, Helen Katrina Tayton-Martin is registered as adm. dir. of Evaxion A/S.
As of November 23, 2025, Birgitte Rønø has stepped down as adm. dir. of Evaxion A/S.
As of July 1, 2025, Birgitte Rønø is registered as adm. dir. of Evaxion A/S.
As of June 30, 2025, Christian Kanstrup has stepped down as adm. dir. of Evaxion A/S.
Evaxion A/S has published its annual report for 2024. Revenue came to DKK 22,324,000, and the net result was DKK -73,277,000.
As of April 30, 2025, Helen Katrina Tayton-Martin has joined the board of directors of Evaxion A/S.
On April 30, 2025, the company changed its name from EVAXION BIOTECH A/S to Evaxion A/S.
As of January 31, 2025, is registered as an owner of Evaxion A/S with an ownership share of 90%.
About Evaxion A/S
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 44 employees (2026). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.